ResearcherDuke UniversityActive in the last 2 years
Suna Erdem
Matched on ORCID iD 0009-0008-6578-5474; OpenAlex author ID A5082495157. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2020: 3 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers
Papers 7
- Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer - A review. Co-author DOI 10.1016/j.heliyon.2023.e23551↗
- Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment. Co-author DOI 10.1158/1535-7163.mct-23-0572↗
- Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metasta… Co-author DOI 10.1136/jitc-2022-006133↗
- Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthotopic murine pancreatic cancer model. Co-author DOI 10.1007/s12672-022-00483-4↗
- Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node … Co-author DOI 10.1007/s00423-020-01859-2↗
- Role of lymphadenectomy in resectable pancreatic cancer. Co-author DOI 10.1007/s00423-020-01980-2↗
- Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model. Co-author DOI 10.1016/j.surg.2020.04.059↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rebekah Ruth White · 6 shared papers, 2020–2024 · strength 1.03
- Paper Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer - A review. DOI 10.1016/j.heliyon.2023.e23551↗
- Paper Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the… DOI 10.1158/1535-7163.mct-23-0572↗
- Paper Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic imm… DOI 10.1136/jitc-2022-006133↗
- Jayanth S. Shankara Narayanan · 5 shared papers, 2020–2024 · strength 0.89
- Paper Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer - A review. DOI 10.1016/j.heliyon.2023.e23551↗
- Paper Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the… DOI 10.1158/1535-7163.mct-23-0572↗
- Paper Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic imm… DOI 10.1136/jitc-2022-006133↗
- Mathias Worni · 3 shared papers, 2020–2024 · strength 0.52
- Paper Local ablative therapies and the effect on antitumor immune responses in pancreatic cancer - A review. DOI 10.1016/j.heliyon.2023.e23551↗
- Paper Role of lymphadenectomy in resectable pancreatic cancer. DOI 10.1007/s00423-020-01980-2↗
- Paper Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreat… DOI 10.1007/s00423-020-01859-2↗
- Partha Ray · 3 shared papers, 2020–2023 · strength 0.42
- Paper Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic imm… DOI 10.1136/jitc-2022-006133↗
- Paper Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthoto… DOI 10.1007/s12672-022-00483-4↗
- Paper Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model. DOI 10.1016/j.surg.2020.04.059↗
- Diego A. Vicente · 2 shared papers, 2020–2022 · strength 0.26
- Steven C. Katz · 2 shared papers, 2020–2022 · strength 0.26
- Yuan Chen · 1 shared paper, 2024 · strength 0.19
- Jorge de la Torre Medina · 1 shared paper, 2024 · strength 0.19
- Andrew M. Lowy · 1 shared paper, 2024 · strength 0.19
- Stephen Philip Schoenberger · 1 shared paper, 2023 · strength 0.16
- Hervé Tiriac · 1 shared paper, 2023 · strength 0.16
- René Warschkow · 1 shared paper, 2020 · strength 0.11
- Dan German Blazer · 1 shared paper, 2020 · strength 0.11
- Beat Gloor · 1 shared paper, 2020 · strength 0.11
- Bruno Martin Schmied · 1 shared paper, 2020 · strength 0.11
- Daniel P. Nussbaum · 1 shared paper, 2020 · strength 0.11
- Benedict A. Capacio · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.